Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Renal Research Institute

ClinicalTrials.gov lists Renal Research Institute as lead sponsor of 19 trials. It has 1 approved asset.

US Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

4 0 1999 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Renal Research Institute: 19 lead-sponsored trials and 1 legal-entity registration.

Get the Renal Research Institute report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (14)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Renal Insufficiency, Chronic 21
Kidney Failure, Chronic 14
Hypertension 4
Edema 2
Hypoxia 2

Showing 5 of 14 disease areas.

Start your 14-day trial Email me all 14 disease areas as a PDF

Trials by start year as sponsor or collaborator (18)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2023 2
2020 2
2019 2
2017 2
2016 3
2015 1
2014 1
2012 2
2011 4
2010 2

Showing 10 of 18 years.

Start your 14-day trial Email me all 18 years as a PDF

Recruitment duration, a model prediction: none of the 19 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Approved assets (1)

Approved assets
Drug Trials
Paricalcitol 1

Journals published in (28)

Shown in this order: most published in first.

Journals published in
Journal Publications
Kidney international 6
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 5
Hypertension (Dallas, Tex. : 1979) 4
The International journal of artificial organs 3
ASAIO journal (American Society for Artificial Internal Organs : 1992) 2

Showing 5 of 28 journals.

Start your 14-day trial Email me all 28 journals as a PDF

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
5 0 2012-09-04

Latest dated events (40)

Shown in this order: newest first.

Latest dated events
Date Event Source
2023-12-11 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-05-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2020-11-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2020-01-08 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2019-09-24 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 40 events.

Start your 14-day trial Email me all 40 events as a PDF

Biomarker capability evidence (6)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
ALB Trial sponsor Named in trial inclusion criteria
CCNG1 Trial sponsor Named in trial inclusion criteria
PTH Trial sponsor Named in trial inclusion criteria
ALB Trial sponsor Mentioned in trial text
CCNG1 Trial sponsor Mentioned in trial text

Showing 5 of 6 evidence rows.

Start your 14-day trial Email me all 6 evidence rows as a PDF

Biomarkers this organization publishes on (40)

Shown in this order: most publications first.

Biomarkers this organization publishes on
Biomarker Publications
IL6 5
ALB 3
EPO 3
HLA-G 3
TNF 3

Showing 5 of 40 biomarkers.

Start your 14-day trial Email me all 40 biomarkers as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, and clia clinical laboratory certificates.